Translating the Science of Primary, Secondary, and Tertiary Prevention to Inform the Public Health Response to Diabetes
- 1 November 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 9 (Supplement) , S8-S14
- https://doi.org/10.1097/00124784-200311001-00002
Abstract
Diabetes is emerging as a major focus of public health efforts in the United States and worldwide because the burden of the disease is increasing rapidly. The increasing prevalence of diabetes is alarming because of the broad spectrum of acute and long-term complications that typically occur in combination and lead to extensive disability and substantial mortality, while imposing substantial human and economic costs on individuals, families, communities, health care systems, and society. Diabetes management was once considered the domain of the physician–patient relationship, guided by basic science and clinical research. Research focused on the physician–patient relationship is now being complemented with risk reduction media campaigns, health services research, and community-based participatory research. This article summarizes key scientific studies of primary, secondary, and tertiary prevention that provide evidence that diabetes complications can be prevented and controlled. We also discuss how findings from large-scale randomized clinical trails support the critical need for complementary public health approaches to address and eliminate persistent health disparities, using health systems, health communications, and community intervention research and practice.Keywords
This publication has 10 references indexed in Scilit:
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic WomenDiabetes, 2002
- Self-Management Education for Adults With Type 2 DiabetesDiabetes Care, 2002
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- A Diabetes Report Card for the United States: Quality of Care in the 1990sAnnals of Internal Medicine, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- The Diabetes Quality Improvement ProjectDiabetes Care, 2001
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Screening for type 2 diabetes.Diabetes Care, 2000
- Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projectionsDiabetes Care, 1998